triple glp 1 agonist Schematic illustration of monoagonists, dual agonists and Incretin-based therapies in MASLD/MASH: from

This guide examines peer-reviewed research on EVOO and GLP-1 secretion, hydroxytyrosol and insulin sensitivity, oleocanthal and inflammation, and why these olive-specific compounds are distinct from other dietary polyphenols

Discover how GLP-1 receptor agonists like semaglutide may reduce inflammation beyond blood sugar control

New analyses involving more than 100,000 patients suggest that users of popular diabetes and weight-loss medications face a lower risk of developing certain cancers and a reduced risk of metastasis.

Years after approving three glucagon-like peptide-1 (GLP-1) receptor agonists to treat obesity, the U.S

Retatrutide vs Semaglutide: Evidence-based comparison of the investigational triple GIP/GLP-1/glucagon agonist versus the FDA-approved GLP-1 agonist

Compounded GLP 1 and Dual GIP/GLP 1 Receptor Agonists: A Statement from the @AmDiabetesAssn